Thus, the CARD9 knockout‐related inhibition of NF‐κB and P38 MAPK activity is likely to be a useful approach in alleviating the inflammatory response in diet‐induced metabolic disorders. The gene discussed is NFKB1; the disease is Other metabolic disease.